TONON, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 4.388
AS - Asia 3.762
EU - Europa 3.174
SA - Sud America 1.362
OC - Oceania 194
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.956
Nazione #
US - Stati Uniti d'America 4.083
SG - Singapore 1.417
BR - Brasile 1.137
CN - Cina 1.024
HK - Hong Kong 641
IT - Italia 550
SE - Svezia 453
GB - Regno Unito 384
RO - Romania 327
DE - Germania 323
VN - Vietnam 311
CA - Canada 220
AU - Australia 193
RU - Federazione Russa 174
AT - Austria 113
AR - Argentina 107
FR - Francia 94
FI - Finlandia 90
JP - Giappone 89
NL - Olanda 88
PL - Polonia 76
MX - Messico 72
CH - Svizzera 70
IN - India 67
CZ - Repubblica Ceca 65
LT - Lituania 60
ES - Italia 55
EC - Ecuador 43
BD - Bangladesh 39
NO - Norvegia 37
ZA - Sudafrica 37
ID - Indonesia 36
AL - Albania 34
DK - Danimarca 31
TR - Turchia 30
UA - Ucraina 27
BE - Belgio 24
EE - Estonia 24
IQ - Iraq 22
RS - Serbia 22
IE - Irlanda 20
CO - Colombia 19
PY - Paraguay 18
PK - Pakistan 15
CL - Cile 14
MA - Marocco 14
VE - Venezuela 14
UZ - Uzbekistan 11
GR - Grecia 10
SA - Arabia Saudita 7
DO - Repubblica Dominicana 6
AE - Emirati Arabi Uniti 5
CM - Camerun 5
MY - Malesia 5
TW - Taiwan 5
BG - Bulgaria 4
IR - Iran 4
MK - Macedonia 4
PS - Palestinian Territory 4
UY - Uruguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
BN - Brunei Darussalam 3
CY - Cipro 3
DZ - Algeria 3
EG - Egitto 3
LB - Libano 3
PE - Perù 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
BW - Botswana 2
GD - Grenada 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PH - Filippine 2
SX - ???statistics.table.value.countryCode.SX??? 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GY - Guiana 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 12.952
Città #
Dallas 1.523
Singapore 652
Hong Kong 640
Ashburn 413
Los Angeles 256
Hefei 232
Shanghai 225
Milan 190
London 178
Sydney 175
New York 138
Beijing 137
Lawrence 137
Princeton 137
São Paulo 133
Montreal 123
Ho Chi Minh City 120
Frankfurt am Main 114
Nuremberg 86
Moscow 81
Tokyo 71
Warsaw 69
Vienna 67
Prague 64
Buffalo 62
Toronto 59
Paris 57
Stockholm 57
Amsterdam 56
Hanoi 56
Helsinki 55
Orem 52
Zurich 46
Acalanes Ridge 44
Rio de Janeiro 42
Santa Clara 38
Piscataway 36
Waterbury 35
Boardman 34
Mexico City 32
Tirana 32
Copenhagen 31
Madrid 30
Munich 30
Oslo 28
Poplar 27
Washington 27
Lombard 26
Phoenix 26
Rome 26
Charlotte 25
Brussels 24
Tallinn 24
Turku 23
Belgrade 22
Edison 22
Houston 22
Chennai 21
Curitiba 21
Guangzhou 21
Brooklyn 20
Dublin 20
Guayaquil 20
Atlanta 19
Buenos Aires 19
Denver 19
Segrate 19
Bern 18
Boston 18
The Dalles 18
Bucharest 17
Johannesburg 17
Sao Paulo 17
Falkenstein 16
Seattle 16
Fortaleza 15
Haiphong 15
Manaus 15
Belo Horizonte 14
Brasília 14
Brisbane 14
Goiânia 14
Guarulhos 14
Kyiv 14
Manchester 14
Baltimore 13
Cesano Boscone 13
Chicago 13
Abbeville 12
Tianjin 12
Brescia 11
Campinas 11
Lappeenranta 11
Porto Alegre 11
San Francisco 11
Athens 10
Columbus 10
Da Nang 10
Istanbul 10
Miami 10
Totale 7.814
Nome #
The 1+Million Genomes Minimal Dataset for Cancer 4.063
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 126
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 122
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 104
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 100
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 99
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 91
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 83
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches. 79
A whole-genome sequencing study associates GRAMD1B with multiple sclerosis risk and disease activity 79
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation 77
Global transcriptomic changes occur in uterine fluid-derived extracellular vesicles during the endometrial window for embryo implantation 74
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 72
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 70
A federated learning system for precision oncology in Europe: DigiONE 70
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 67
Iron increases the susceptibility of multiple myeloma cells to bortezomib 66
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 66
Analyzing genomic and epigenetic profiles in single cells by hybrid transposase (scGET-seq) 65
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 65
A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands 62
Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics 62
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma 61
ATR addiction in Multiple Myeloma: synthetic lethal approaches exploiting established therapies 61
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 61
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 60
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer 60
Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation (Scientific Reports, (2020), 10, 1, (16906), 10.1038/s41598-020-73835-1) 60
A next generation sequencing study in Italian multiplex families with multiple sclerosis 60
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 57
An Oncogene-Regulated Epigenetic Switch in T Cell Acute Lymphoblastic Leukemia 57
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 56
A whole-genome epigenomic approach in multiple sclerosis multiplex families revealed new epigenetic traits involved in the disease 56
A "static" karyotype in epithelial cancer cell lines despite ongoing chromsomal instability 56
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 56
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 55
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 55
Chest CT in the emergency department for suspected COVID-19 pneumonia 55
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection 53
A "static" karyotype in epithelial cancer cell lines despite ongoing chromosomal instability 53
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 53
Whole-genome epigenomic approach in multiplex families with multiple sclerosis revealed new epigenetic traits involved in the disease 51
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression 51
Extracellular vesicles secreted by human aneuploid embryos present a distinct transcriptomic profile and upregulate MUC1 transcription in decidualised endometrial stromal cells 51
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 50
RADIOMIC AND GENOMIC APPROACHES FOR THE ENHANCED DIAGNOSIS OF RENAL CANCER (REDIRECT): A TRANSLATIONAL PILOT STUDY 50
Rete IDEA: solving the unsolved diagnoses of primary immunodeficiency 50
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans 49
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 48
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 48
CS1, a new surface target on multiple myeloma (MM) cells, protects myeloma cells from apoptosis via-regulation of ERKI/2, AKT and STAT3 signaling cascades 48
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 47
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL 47
Genomics in Multiple Myeloma: From Conventional Cytogenetics to Novel Whole-Genome Sequencing Approaches 47
Somatic mutations affect key pathways in lung adenocarcinoma 46
UNCAN.eu: Toward a European Federated Cancer Research Data Hub 45
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism 45
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells 45
Karyotypic complexity of the NCI-60 drug-screening panel. 45
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history 44
A Whole-Exome Sequencing Study In Multiple Sclerosis Multiplex Families 44
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 44
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 44
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus 44
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 44
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation 43
RNA sequencing of blood from sex- and age-matched discordant siblings supports immune and transcriptional dysregulation in autism spectrum disorder 43
Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas 43
Identification of a truncated ADP-activated P-2X1 receptor in platelets and megakaryocytic cell lines 43
Identification of new human liver cancer genes by a novel lentiviral vector-based insertional mutagenesis approach in three mouse models of hepatocarcinogenesis 43
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer 42
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers 42
FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy 41
A whole-exome sequencing approach in multiplex Italian multiple sclerosis families to identify new genes involved in the disease 41
C-Myc- Dependent Stabilization of Hif-1alpha in MM: Therapeutic Implications 41
DNA methylation alterations in prostate cancer: from diagnosis to treatment 40
Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy 40
Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features 40
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients 40
Novel Therapeutic Targets in Multiple Myeloma 40
Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure. 40
Common and contrasting genomic profiles among the major human lung cancer subtypes 39
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 39
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway 39
H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing 39
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets 39
In vitro and in vivo activity of the VEGF inhibitor pazopanib 39
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 38
Expression of apoptotic markers in activated platelets is mediated in part by cathepsin 38
INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS 38
JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment 37
Loss of the histone demethylase UTX alters the gene expression prolife and contributes to the malignant phenotype of multiple myeloma cells 37
Telomere dysfunction induces metabolic and mitochondrial compromise. 37
Synthetic Lethal Approaches to Exploit Replicative Stress in Aggressive Myeloma 37
Genetic distance, transportation costs, and trade 37
Nizp1 is a specific NUP98-NSD1 functional interactor that regulates NUP98-NSD1-dependent oncogenic programs 36
IRON CONTRIBUTES TO BORTEZOMIB SENSITIVITY IN MULTIPLE MYELOMA CELLS 36
Genomic Instability and Replicative Stress in Multiple Myeloma: The Final Curtain? 36
MATRIGEL CAPILLARITY-DRIVEN FILLING IN OPEN MICROFLUIDICS FOR HIGH-THROUGHPUT DRUG SCREENING ON 3D PATIENT DERIVED ORGANOIDS CULTURES 36
MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer 36
Totale 9.349
Categoria #
all - tutte 72.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 4 5 0 0 0 0 0
2021/2022156 0 0 0 12 2 0 2 121 2 11 1 5
2022/2023800 287 178 31 7 48 114 33 59 15 8 13 7
2023/2024433 10 14 47 124 30 53 15 29 1 25 23 62
2024/20256.214 250 59 88 123 112 261 739 365 505 2.699 761 252
2025/20265.624 745 945 1.605 1.443 755 131 0 0 0 0 0 0
Totale 13.254